Corcept Therapeutics | CORT - صافي الدخل





صافي الدخل تغيير تاريخ
Acadia Pharmaceuticals USD 3.64M 269.93M 2026-03
Alaunos Therapeutics USD -1.16M 108K 2025-09
ANI Pharmaceuticals USD 29.49M 2.86M 2026-03
Ardelyx USD -407K 562K 2025-12
Assertio Holdings USD -2.92M 753K 2024-09
Aurora Cannabis CAD 1.82M 53.29M 2025-12
BioMarin Pharmaceutical USD 105.53M 152.1M 2026-03
Bristol-Myers Squibb USD 2.68B 1.59B 2026-03
Canopy Growth CAD -62.63M 60.99M 2025-12
Corcept Therapeutics USD -31.76M 56.05M 2026-03
Eli Lilly USD 7.4B 760M 2026-03
Esperion Therapeutics USD 61.83M 93.16M 2025-12
J&J USD 5.24B 119M 2026-03
Knight Therapeutics CAD -3.79M 8.83M 2025-09
Lexicon Pharmaceuticals USD -15.53M 2.76M 2025-12
Merck USD -4.24B 7.2B 2026-03
Nektar Therapeutics USD -36.08M 978K 2025-12
Novartis USD 3.16B 747M 2026-03
Novartis USD 2.41B 1.52B 2025-12
Omeros USD -32.23M 23.81M 2024-09
Pacira USD 2.92M 1.28M 2026-03
Pfizer USD 2.69B 4.34B 2026-03
Supernus Pharmaceuticals USD -2.29M 1.81M 2026-03
TG Therapeutics USD 19.78M 3.26M 2026-03